The latest at MBC Biolabs
The latest at MBC Biolabs
Symic Adds Expertise to its Board
Symic Biomedical announced today the appointment of Barbara Yanni and William J. Newell to its bo [...]
Amarantus to Present Positive Alzheimer’s Disease Biomarker Data
Amarantus announced that its abstract titled "The LymPro® Assay: A Biomarker For Alzheimer's Dise [...]
MedGenome to Raise $15M in Second Round of Funding
MedGenome, backed by Mu Sigma co-founders Dhiraj Rajaram and Ambiga Dhiraj, is looking to raise $ [...]
Amarantus Inks Alzheimer’s Biomarker Test Deal with Anavex
Amarantus BioScience Holdings today said that it has signed a deal to provide biomarker test serv [...]
Senior Management Changes at Assembly Biosciences
Co-founder Derek Small succeeds Russell H. Ellison, MD, as CEO, as had been agreed in the merger [...]
John Mulcahy, SiteOne Therapeutics
Developing a non-addictive painkiller to compete with opiates Mission Bay Capital portfolio comp [...]
Colleen Cutcliffe, Whole Biome
Improving human health by sequencing and analyzing the microbiome and developing targeted therapi [...]
Uri Lopatin, Assembly Biosciences
Targeting the hepatitis B virus Ramen to reverse merger in under two years. Uri Lopatin co-founde [...]
MedGenome keen to team-up with state govts
MedGenome is looking to partner with the state governments in the country to offer its OncoMD, a [...]
Innovation in fixed-dose combos: HIV/AIDS therapeutics edition
The FDA has published guidance to support the submission process for companies developing fixed-d [...]
It’s free! QB3 inks equipment donation deal for biomed startups
One of the lures of the University of California's QB3 incubator network for life sciences startu [...]